Hikma PharmaceuticalsCompany Review & Valuation

HIK
London Stock Exchange
Latest Price
2,510.00GBP
Market Capitalization
578.54bGBP

About Hikma Pharmaceuticals plc

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactShow moreures, markets, and sells generic injectable products for therapeutic categories, including anti-infective, anaesthetic, central nervous system (CNS), oncology, and pain management, as well as controlled substances and cardiovascular products. The Generics segment develops and sells approximately 100 oral and other non-injectable generic products for oncology and pain management, as well as respiratory, nasal spray, suspension, liquid solution, and high-containment areas. The Branded segment develops, manufactures, and markets branded generics and in-licensed products, such as anti-infective products, as well as chronic therapeutic categories comprising cardiovascular, diabetes, CNS, and oncology products. The company also manufactures plastic specialized medicinal sterile containers and APIs; and conducts bio-equivalency studies. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.Show less

Industry
Drug Manufacturers - Specialty & Generic
HQ Location
London, United Kingdom

Stock Price

Price data not available for Hikma Pharmaceuticals.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Shionogi
Perrigo
Allergan
BioGaia

back to top